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Abstract
Objectives and background: The effect of headache on cognitive performance is controversial, due to conflicting
results obtained from studies in clinical or population settings. We aimed to understand if migraine and other
headaches modify the rates of decline on different cognitive measures, during a 5-year interval.
Design and method: A cohort of community dwelling adults (> 50 years) with migraine (MH), non-migraine
headaches (NMH) and controls without headache (WoH), was assessed by a comprehensive neuropsychological
battery with tests of memory, language and executive functions, repeated 5 years apart. Change in performance
between baseline and reevaluation was compared between groups, and controlled for age, gender, literacy and
depressive symptoms.
Results: A total of 275 participants (78.5% WoH, 12.7% MH, 8.7% NMH) were reevaluated (average age 70.40 + 8.34
years, 64% females). Cognitive decline or dementia occurred in 11.4%, with a similar proportion among the three
groups. Although MH participants had significantly more subjective cognitive complaints (p = 0.030, 95%CI:]-3.929,-
0.014[), both MH and NMH subjects showed an age-associated decline identical to controls. Furthermore, migraine
features (disease and attack duration, frequency and aura) were unrelated with cognitive performance.
Conclusion: Migraine and non-migraine headache are not associated with increasing risk of dementia or cognitive
decline at an older age although subjects with migraine have more cognitive complaints. Longer longitudinal
studies are necessary to understand if this pattern persists for more than 5 years.
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Short summary
This study shows that older individuals with migraine and
other headaches do not have an increased risk of cognitive
decline, cognitive impairment or dementia than subjects
without headaches, over a period of 5 years. However, sub-
jects with migraine tend to present more subjective cogni-
tive complaints compared to people without headaches.
Longer studies are necessary to understand the impact of
these complaints during aging.
Introduction
The interaction between migraine and cognition is dy-
namic and seems to fluctuate along the migraine cycle.
Cognitive symptoms are a very consistent feature of the
attacks [1, 2] and have been substantiated by the finding
of neuropsychological impairments in executive func-
tions, memory and learning that revert to normal after
the attack [3, 4]. However, the brain processes under-
lying these phenomena remain speculative.
Some patients also complain of cognitive changes out-
side the attacks, and cross-sectional controlled inter-ictal
studies, in clinically based samples, have identified negli-
gible to small effects of migraine on visuomotor process-
ing speed, sustained attention, verbal learning and recall,
prospective and working memory [5–11], that tend to be
more expressive in some patient subgroups, such as mi-
graine with aura and severe or chronic migraine [12, 13].
The finding of inter-ictal brain imaging structural and
perfusion changes in migraineurs [14, 15] supported the
hypothesis that migraine associated white matter abnor-
malities and brain lesions [16, 17] could increase the risk
of late-life cognitive impairment or dementia.
However, most cross-sectional studies on population-
based samples, using less detailed neuropsychological evalu-
ations, were unable to document such changes [12, 13], al-
though a few studies with extensive batteries and large
samples identified worse [18] or even better [19] cognitive
performance in migraine patients. Nevertheless, evidence
obtained from large population-based longitudinal studies
does not associate migraine to an increased risk of cognitive
decline [20–23] nor to the progression of white matter ab-
normalities or infarct-like lesions [24].
This contrasting evidence stimulated the debate on
whether cognitive changes identified in migraine pa-
tients, regardless of the setting, are specific to migraine
and/or headache or due to confounders. In fact, execu-
tive and cognitive impairments have also been docu-
mented in other chronic or recurrent pain disorders
[25]. Moreover, migraine sufferers have a higher risk of
depression and anxiety and may take medication that in-
terferes in cognitive performance. On the other hand,
they may also have protective factors, such as a lower
exposure to vascular risk factors due to the adoption of
a healthier lifestyle in order to avoid the attacks, and/or
to better disease prevention attitudes related to more
frequent need to seek medical attention [26].
In a previous cross-sectional study, we compared the
inter-ictal cognitive performance of adults with or without
headaches or migraine, concluding that most cognitive
functions and tests were not influenced by the presence of
migraine or non-migraine headache in late adult life [27].
However, both subjects with migraine and non-migraine
headache performed worse in a few executive tests, sug-
gesting that persistent or recurrent pain could have some
impact on executive functioning. Executive abilities are
known to be particularly vulnerable to both normal cogni-
tive ageing [28] and subcortical white matter changes [29],
and therefore the question is raised on how these impair-
ments could evolve over time.
In the current study, we aimed to determine if mi-
graine and non-migraine headaches in adult life modify
the rates or processes of cognitive aging, specifically ex-
ecutive functioning and memory, by comparing cognitive
changes between baseline and a 5-year follow-up, be-
tween subjects with and without headaches or migraine.
Our hypothesis was that there should be no difference
between participants with headache and controls.
Methods
Participants and study design
This was a prospective longitudinal observational study
on aging and cognition involving a cohort of 402
community-dwelling adult volunteers attending primary
care centers of the National Health Service in the region
of Lisbon. Subjects were screened and invited to partici-
pate by their general practitioner provided that, at incep-
tion, they had a minimum age of 50 years, spoke
Portuguese as their native language, were autonomous
for instrumental daily living activities and scored within
literacy-adjusted normal values [30] on the Mini Mental
State Evaluation (MMSE) [31]. Exclusion criteria in-
cluded a history of any neurologic or psychiatric disease
(ex. stroke, brain injury, epilepsy, dementia or psychosis)
and any severe medical disorder with potential influence
on neurological function (ex. cancer, HIV infection,
renal or hepatic failure). Further details of the study de-
sign and baseline evaluation have been published else-
where [27].
The participants of this study came from a cohort tak-
ing part in a prospective cross-sectional study composed
by 479 subjects that performed a baseline assessment
[32]. However, 77 of those were excluded from the lon-
gitudinal follow up because they could not be reached
due to both unknown contact/mailing address and insuf-
ficient updated clinical information (N = 53), or cur-
rently living outside the Lisbon Metropolitan region
(N = 24). This produced a cohort of 402 participants eli-
gible for follow-up assessment. From these, 127 were
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considered lost to follow-up due to refusal to participate
(N = 109), death (N = 15) and terminal medical illness
(N = 3) (see Fig. 1). This led to a final cohort of 275 sub-
jects that participated in the follow-up part of the study
after an average time interval of 4.9 (±0.6) years (Fig. 1).
The study was carried out in accordance with the rec-
ommendations of the Ethics Committee of the Lisbon
Academic Medical Center (LAMC). All subjects gave
written informed consent in accordance with the Declar-
ation of Helsinki, for both parts of the study. The proto-
col was approved by the Ethics Committees of the
LAMC, the Portuguese Health Authority and local pri-
mary care centers.
Measures and procedures
The following data were collected on both periods of the
study: (1) medical history, including vascular risk factors
(hypertension, diabetes, smoking history and dyslipid-
emia), co-morbidities, and medication; (2) sociodemo-
graphic data (employment, cohabitation and marital
status); (3) subjective cognitive complaints and depres-
sive symptoms; and (4) cognitive performance.
Neuropsychological evaluations were performed by
fully licensed neuropsychologists. It comprised the
MMSE [31], tests of episodic memory [Verbal-Paired
Associates, Immediate and Delayed Logical Memory and
Visual Reproduction from Wechsler Memory Scale – III
(WMS-III) [33]] and the 9-item version of the California
Verbal Learning Test [34]), semantic memory [Vocabu-
lary subtest from Wechsler Abbreviated Scale of
Intelligence (WASI) [35]] attention/processing speed
[Symbol search, Wechsler Adult Intelligence Scale-III
(WAIS-III) [36]], and executive functions (Trail Making
Test A and B (TMT-A an TMT-B)] [37], Stroop Test
[38, 39] and Digit Span Backwards [36]). Language skills
were assessed by semantic (Food and Animals) and
phonemic Verbal Fluency. Individual scores were con-
verted to age and education-adjusted z-scores according
to the existing norms [40, 41].
In addition, the 15-item Geriatric Depression Scale
[42], a subjective memory complaints questionnaire
(SMCQ) [43] and the Instrumental Activities of Daily
Living Scale (IADL) [44] were also applied.
Cognitive status
For the purpose of summarizing cognitive data and clas-
sifying the subjects, an executive and a memory function
composite score were calculated, resulting from the
average standard scores obtained on five executive tests
[(Ʃ Z Trail Making Test A + Z Trail Making Test B + Z
Semantic Food Fluency + Z Semantic Animals Fluency +
Z Phonemic Fluency)/5] and two episodic memory tests
[(Ʃ Z Logical Memory + Z Verbal Paired Associates)/2],
respectively. An additional global cognitive score was
obtained consisting of the mean of memory and execu-
tive composite scores [(Ʃ Composite executive + Ʃ Com-
posite memory) / 2].
Individuals were classified as cognitively impaired/de-
mentia if they scored below − 1.5 standard deviations on
any of the composite scores (dementia if they also had
Fig. 1 Flowchart of study participants from baseline to follow-up
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impaired daily living activities). This cut-off is frequently
used to define mild cognitive impairment (MCI), it al-
lows for the identification of a large number of cases
qualifying for this diagnosis [45–47] and the diagnosis
made using this cut-of has been significantly associated
with measures of medial temporal atrophy and APOE
genotype status [48]. These two diagnoses were further
confirmed by an interview with their family.
The diagnosis of cognitive impairment/dementia was
done in accordance to published criteria [49, 50] and has
already been described in previous work [32]. The diag-
nosis was reached by consensus after consulting and
analyzing the results obtained on memory and executive
tests (memory or executive composite scores should be
below - 1.5 SD), and the review of all available clinical,
neuropsychological, and imaging data by a panel of two
neurologists and two neuropsychologists. Whenever pos-
sible, an independent clinical evaluation was performed
in a research center (not presented in study data) with a
minimum interval of 6 months after study testing, to
confirm the diagnosis of cognitive impairment. Partici-
pants were considered cognitively normal if they
remained independent in daily living activities and
scored at or above − 1.5 SD on both composite indexes.
Migraine status
Headache status at baseline was classified as without
headache (WoH) or with headache, which was further
subdivided, according to the score obtained on the Por-
tuguese version [51] of ID Migraine [52] into migraine
headache (MH; if ID-Migraine score was ≥2) or non-
migraine headache (NMH; ID-Migraine < 2).
Patients with MH at baseline were additionally con-
tacted by telephone and systematically assessed for the
current occurrence of headaches and details of headache
history (disease duration, presence of aura, frequency
and duration of attacks and headache impact, measured
with HIT-6 [53]).
MRI protocol and evaluation
Brain magnetic resonance imaging (MRI) was performed
on a 3 Tesla Phillips scanner. The MRI protocol in-
cluded conventional sequences: T13D TFE with sagittal,
coronal and axial reconstructions; Axial PD/T2, FLAIR,
T2* GRE and diffusion MR images. Brain MRIs were
visually assessed by a neuroradiologist (JT), blind to mi-
graine and cognitive diagnosis, to identify structural
brain changes, namely white matter changes with the
Fazekas scale [54, 55], and regional cerebral atrophy
namely medial temporal atrophy (MTA) scale [56]. These
measures were used as biomarkers of brain disease.
Scores from both scales were subsequently dichotomized
into normal or minor changes (scores 0–1 and moderate
to severe changes (scores 2–3).
Statistical analysis
Statistical analysis was performed with the SPSS package
21.0. Descriptive statistics were used for continuous vari-
ables and presented as mean ± standard deviation.
Counts and frequencies were used for categorical vari-
ables. Group differences were tested using one-way Ana-
lysis of Variance (ANOVA) or t-tests, when appropriate,
for continuous variables or Chi-Square (χ2) tests for cat-
egorical variables. Normal distribution assumption was
tested by the Kolmogorov-Smirnov test. Whenever this
assumption was violated nonparametric tests were used.
To investigate whether the presence of headache and
migraine were associated with increased risk of cognitive
impairment/dementia at follow-up, a logistic regression
analysis was performed after controlling for gender, age
at follow-up and depressive symptoms. In order to
analyze the main effects of time (baseline vs follow-up)
and group (MH, NMH and who) as independent factors
on cognitive performance we used a mixed-repeated
measures ANOVA and post-hoc Bonferroni tests, after
controlling for gender, age at baseline and depressive
symptoms. An additional matched case-control analysis
was performed. Migraine patients were matched for age,
literacy and gender to non-migraine patients (1:2 ratio).
A bivariate and a multivariate conditional logistic regres-
sion were computed using the same variables as above.
Results were considered statistically significant at p <
0.05. Parameter uncertainty was indicated by the 95%CI.
No statistical power calculation was conducted prior to
the study. The sample size was based on the available
data. We estimated that our study would be able to de-
tect a medium effect.
Results
The follow-up study population included 275 individ-
uals. Of these, 176 (64%) were female, with an average
age of 70 years (ranging between 55 and 98 years). Con-
cerning the headache diagnosis, 216/275 (78.5%) subjects
were headache-free, 35/275 (12.7%) had migraine and
24/275 (8.7%) non-migraine headache. Retention rates
by group were 69% for WoH, 73% for MH and 58.5% for
the NMH groups. Mean follow-up times were identical
between groups (p = 0.909).
Participant characteristics and imaging data by headache
diagnosis
Differences between groups in demographic, imaging
and clinical data are depicted in Table 1. Migraine par-
ticipants were more often female, younger, had more de-
pressive symptoms and more subjective memory
complaints than WoH subjects. The number of subject-
ive cognitive complaints was significantly different
among headache groups, after controlling for age and
depressive symptoms (F = 3.926; p = 0.021), being higher
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at baseline and remaining high and stable with aging in
MH as opposed to NMH subjects (mean diff. = − 2.037,
p = 0.030, 95%CI:]-3.929, − 0.014[) in whom they in-
creased with age (Fig. 2). No statistical differences were
found between the three groups on literacy, MMSE
scores or vascular risk factors (Table 1).
A total of 159 of these participants had an MRI evalu-
ation, 120 from the who group, 13 with NMH and 23
from the MH group. No significant differences were
found between groups regarding either white matter
changes or atrophy measures (Table 1).
Risk of cognitive impairment/dementia
Cognitive decline/dementia was documented in 31/
275(11.3%) of the reevaluated sample with similar pro-
portions in subjects with MH (χ2 = 1.239, p = 0.537),
NMH and WoH (Table 1).
After controlling for gender, age at follow-up and de-
pressive symptoms, the presence of migraine or nonmi-
graine headache were not significant predictors of
cognitive impairment at follow-up. Age at follow-up was
a significant predictor (Table 2). The model showed ad-
equate calibration (Hosmer Lemeshow test χ2 = 10.051;
p = 0.189).
In the matched case-control analysis, there was no sig-
nificant association between migraine and cognitive im-
pairment as well, both in the bivariate analysis (p = 1.00,
OR = 1, 95% CI [0.09–11.92]) and in the multivariate
analysis (p = 0.778, OR 1.58, 95% CI [0.08–28.64]).
Cognitive performance between headache groups
In order to analyze the main effects of time (baseline vs
follow-up) and group (MH, NMH and who) as inde-
pendent factors on cognitive performance we used a
mixed-repeated measures ANOVA and post-hoc Bonfer-
roni tests, after controlling for gender, age at baseline
and depressive symptoms.
All groups showed a significant decline in memory,
from baseline to follow-up (F = 17.878, p < 0.0001), des-
pite a more pronounced slope of decline in WoH and
Table 1 Population characteristics by diagnosis
Without headache (WoH) Non migraine headache (NMH) Migraine headache (MH) Statistics p-value
N 214 24 35
Follow-up timea
(yrs; median [P25th,P75th])
5.1 [4.7,5.3] 5.0 [3.8,5.4] 5.2 [4.9,5.3] W = 0.192 0.909
Gender
(F:M; n(%))
126 (60%):90 17 (70%):7 33 (94%):2 χ2 = 17.430 < 0.0001
Age at baseline
(yrs; mean ± sd)
65.8 ± 8.4 68.4 ± 6.8 61.1 ± 7.4 F = 6.741 0.001
Age at follow-up
(yrs; mean ± sd)
70.8 ± 8.5 73.0 ± 6.6 66.1 ± 7.3 F = 6.246 0.002
Literacy
(yrs; mean ± sd)
7.8 ± 4.2 6.5 ± 4.4 6.1 ± 4.2 F = 3.040 0.049
MMSEa
(median [P25th,P75th])
29 [28,30] 28 [26,29] 28 [27,29] W = 7.143 0.028
GDSa
(median [P25th,P75th])
2 [1,5] 3 [2,6] 5 [3,8] W= 24.019 < 0.0001
SMCQ
(mean ± sd)
6.2 ± 3.7 6.3 ± 4.1 8.3 ± 3.9 F = 4.584 0.010
Vascular Risk Factors
(0: 1: 2: ≥ 3; n)
25: 71: 144: 86 2: 10: 21: 14 4: 12: 27: 8 χ2 = 4.228 0.646
Cognitive decline
(Yes: No; n(%))




122 (56.5%):94 11 (45.8%):13 28 (80.0%):7 χ2 = 8.615 0.013
Fazekas score
(0-I: II-III; n(%))
82 (68.3%):38 6 (54.5%):5 16 (57.1%):12 χ2 = 1.873 0.392
MTA
(0–1: 2–3; n(%))
111 (90.2%):12 11 (100%):0 28 (100%):0 χ2 = 4.109 0.128
Figures in bold represent statistically significant differences between one group and the others after Bonferroni post hoc test
F females, M males, MMSE Mini Mental State Examination, MTA Medial Temporal Atrophy, GDS Geriatric Depression Scale, SMCQ Subjective Memory
Complaints Questionnaire
p ≤ 0.05 was considered significant
askewness <− 1 or > 1
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NMH groups when compared to MH (Fig. 3). A signifi-
cant interaction between time and age on the perfor-
mace of memory composite score was also identified
(F = 17.556, p < 0.0001). In addition, a significant main
effect of headache type was found on the performance of
executive function (F = 3.706, p = 0.026) but not on
memory composite scores (F = 0.398, p = 0.672). A sig-
nificant interaction between group membership and
time/change was also observed for the executive com-
posite score (F = 4.094, p = 0.018). In this case, the mean
difference was higher in MH (also with an increase in
performance from baseline to follow-up) when com-
pared to WoH group (mean diff. = − 0.424, p = 0.028,
95%CI:]-0.815, − 0.033[). As depicted in Fig. 3, NMH
also showed an increase in executive function perform-
ance over time, although not different from the other
two groups. The bivariate comparisons between head-
ache diagnosis and executive performance at baseline
and at follow up are detailed in Table 3.
Looking into detail at each specific measure of the ex-
ecutive function composite score, a significant main ef-
fect of headache type was observed for both TMT-A
(F = 3.773, p = 0.024) and TMT-B (F = 3.796, p = 0.024)
scores. A significant interaction between headache type
and TMT-A score change was also identified (p = 0.023).
Mean change in TMT-A performance was significantly
higher in the MH group, due to an increase in process-
ing speed score of overtime, when compared to WoH
subjects (mean diff. = − 0.579, p = 0.044, 95% CI:]-1.147,
− 0.011[). As depicted in Fig. 2, MH was the only group
where this improvement was noted, whereas the
remaining groups showed a decline over time.
In order to control for group differences observed in
the baseline evaluation, post-hoc analyses were repeated
using the arithmetical difference between baseline and
follow-up memory and executive function composite
scores. Once again, a significant difference between MH
(− 0.59 ± 1.5) and WoH (0.07 ± 1.0) was observed in ex-
ecutive (F = 4.090, p = 0.018) but not memory perform-
ance (F = 0.376, p = 0.658), although this difference did
not reach statistical significance when analyzing specific
cognitive tests (p values between 0.197 and 0.967).
Fig. 2 Cognitive complaints scores by headache group. Legend: y-axis represent estimated marginal means of Subjective Memory Complaints
Questionnaire scores controlling for age and depressive symptoms; WoH – without headache, NMH – non migraine headache, MH –
migraine headache





p-value OR 95% CI
Inferior Superior
MH 0.289 0.591 0.647 0.132 3.160
NMH 0.012 0.914 0.927 0.238 3.619
Gender 0.696 0.404 0.703 0.308 1.608
Age at follow-up 11.929 0.001 1.088 1.037 1.141
GDS 1.961 0.161 1.084 0.968 1.213
MH migraine headache, NMH non-migraine headache, GDS Geriatric
Depression Scale, OR odds ratio, CI confidence interval
Significance is set at p < 0.05
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Migraine data at follow up
From the 35 MH patients included at baseline, 29 (83%)
were successfully interviewed after the neuropsycho-
logical revaluation and 5/35 were impossible to reach.
Nine patients out of the 35 (31%) reported having aura
with their headaches, but only one patient reported it in
all the attacks. All subjects had migraine for more than
10 years; disease duration was less than 20 years in 11/
35, between 21 and 50 years in 7/35, and between 51 to
70 years in 5/35 cases.
Twenty patients had suffered migraine attacks in the
last year, although in most, their frequency was scarce.
Thirteen (65%) patients had up to one attack per month,
five (25%) had more than 15 monthly headache days
(chronic migraine) and two had daily headache. Average
attack duration was 17.9 ± 22.0 h, ranging from 45min
to 3 days; one of the daily headache patients had con-
tinuous headache. Average HIT-6 score of this sample
was 54.3 ± 11.1 (range 36 to 76). Some patients noticed a
change in their migraine features at follow up, as 11/20
(55%) ceased to have nausea with their attacks, 6/20
(30%) ceased to be disturbed with photophobia and 7/20
(35%) were now able to work and function during their
migraine attacks.
Cognitive performance in migraine
In the MH group, the two patients presenting cognitive
decline had aura (χ2 = 4.320, p = 0.038) but the presence
of aura had no influence on the executive (t = 0.639, p =
0.529.) or memory scores (t = 1.052, p = 0.266). Disease
Fig. 3 Cognitive performance overtime by headache group. Legend: y-axis represent estimated marginal means memory and executive
composite zscores and trail A and B zscores controlling for gender, age at baseline, depressive symptoms; WoH – without headache, NMH – non
migraine headache, MH – migraine headache






Migraine headache (MH) −0.7 ± 1.5 −0.1 ± 1.0 0.0439
Non migraine headache (NMH) −0.5 ± 1.2 −0.1 ± 0.9 0.0455
Without Headache
(WoH)
0.1 ± 1.1 0.03 ± 0.9 0.0969
p-value 0.0004 0.2247
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duration (χ2 = 0.157, p = 0.541), attack frequency (t =
0.332, p = 0.743), attack duration (t = − 1.299, p = 0.210)
and Fazekas score (χ2 = 2.128, p = 0.546) had no associ-
ation with cognitive decline in migraine patients. Also,
MH subjects showing a decline in cognitive functions had
similar HIT-6 scores as those who remained cognitively
normal (t = − 2.216, p = 0.041); the HIT-6 score did not
correlate with the executive function (r = − 0.248, p =
0.307) or memory scores (r = − 0.246, p = 0.269).
Discussion
In this study, we did not find evidence for a) increased
risk of cognitive decline or dementia or b) steeper cogni-
tive decline, over a 5-year period, in subjects with mi-
graine and non-migraine headaches, when compared to
individuals without headache. Nonetheless, we found
that individuals with migraine presented more subjective
cognitive complaints and depressive symptoms than
controls.
The present study included participants mainly be-
tween the 5th and the 7th decades of life and corrobo-
rated previous evidence from population-based
longitudinal studies [20–24], using a variety of cognitive
measures and with follow-up times ranging between 6
and 12 years, showing that persisting migraine in older
adults does not increase the risk of cognitive decline and
does not influence performance in memory and execu-
tive tests. Although the follow-up time can be consid-
ered relatively short, similar intervals were sufficient to
document age-related cognitive decline in population
studies. The effect of non-migraine headache on cogni-
tion has only been studied in the Epidemiology of Vas-
cular Aging (EVA) study [22] and, similarly to our
results, also produced negative findings regarding cogni-
tive performance, despite the fact that subjects with
headaches, particularly migraine with aura, had more
white matter hyperintensities than controls [57]. The
consistency of these results is reassuring and it seems
reasonable to assume that persisting headache and/or
migraine at old age does not increase the risk of cogni-
tive decline.
In general, population-based cross-sectional controlled
studies on cognition in migraine have also been negative
[12, 58], with two exceptions. In one of them, 20% of the
participants suffered from chronic migraine, a disorder
known for having a high impact on subjects’ lives and
several associated co-morbidities that may have biased
the results [18]. The other exception was the cross-
sectional baseline analysis of our own population that re-
vealed lower performance in both MH and NMH sub-
jects on a few executive measures. Interestingly, both
exceptions included participants with low literacy and it
is well known that education is an important determin-
ant of cognitive performance. A large cross-sectional
study, in which about half of the participants had
medium to higher education, produced the opposite
trend, i.e. of a better cognition in migraine subjects [19].
Our study also showed that cognitive decline in migraine
patients was neither associated with measures of migraine
activity, intensity or impact nor with brain biomarkers
(Fazekas scores and cortical atrophy). The lack of associ-
ation between white matter lesion load and poorer neuro-
psychological performance has been previously described
[6] and it can be subject to confounders (e.g., cardio- and
cerebrovascular risk factors, namely hypertension). More-
over a longitudinal imaging study failed to show any pro-
gression of these brain lesions [24] in migraine. Likewise,
migraine aura was unrelated to cognitive change, either in
our sample or in other longitudinal studies [20, 23], al-
though data from cross-sectional studies has produced con-
flicting findings [6, 13]. In our sample, the total number of
migraine patients with cognitive decline was small (2 in
total), limiting speculation about the effect of migraine fea-
tures on decline.
Two additional findings emerged from this study. One
was the different rate of cognitive change with time be-
tween migraine subjects and controls, in particular re-
garding executive function tests. The other was the
consistently high rates of subjective cognitive complaints
in the migraine group, was found both at baseline and
follow-up.
Although most measures (Table 4) showed a tendency
to decline with age, individuals with migraine showed
less decline or even improvement with age in measures
of processing speed and attention. Interestingly, MH
participants also presented lower baseline scores on
those tests compared to controls. A very similar pattern
was described in the Baltimore Ageing study [20], espe-
cially in migraine subjects older than 50 years, who
showed less decline than controls. Since the participants
of the present study had lower scores at baseline, we re-
peated the analysis using the “follow-up minus baseline
difference” as the dependent variable and obtained iden-
tical results. In both studies subjects with migraine were,
on average, younger than controls, and therefore this
may represent the relative sparing effect of younger age
in age-related cognitive decline. Another explanation is
that performance in migraineurs may be more variable
over time, due to cyclic changes in brain excitability [59]
leading to fluctuations in performance that regress to
the mean with test repetition. The finding that migrai-
neurs present variable results in different studies and
contexts supports this hypothesis. The fact that these
fluctuations are more evident in executive tests is not
clear but may be associated with fluctuating attention
[60]. Finally, one may not exclude the possibility that
this late cognitive improvement is related to the decline
of migraine activity with aging, leading to a “return to
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normal” of intermittent brain dysfunction. Our study
was not designed to evaluate the effect of disease activ-
ity, but of disease trait. Close monitoring of migraine
and cognitive functions will be necessary to disentangle
this hypothesis.
The other finding is the association between migraine
and subjective cognitive complaints, a very consistent
finding between baseline and follow-up, in the absence
of decline. Cognitive complaints are common in head-
ache practice and are known to correlate with depressive
symptoms yet, in this study, their number remained high
after controlling for depressive symptoms.
Finally, it is worth mentioning that migraine features
changed over the timespan of 5 years. In this sample,
31% of migraine patients who were reevaluated had no
attacks in the previous year and 65% of those with per-
sistent attacks had less than one attack per month. In
55% of subjects, attacks ceased to be accompanied by
nausea, in 30% the photophobia was no longer present
and 35% had milder attack impact, being now able to
work and function during attacks. These changes in mi-
graine characteristics with aging have been documented
[61, 62], but clearly influence our ability to diagnose mi-
graine and to distinguish it from non-migraine headache,
being a recognized limitation that may influence the re-
sults of cross-sectional studies that rely on a single
evaluation of older individuals.
We acknowledge some limitations in this study. One is
the high attrition rate (around 32%), when compared to
similar length studies that had retention rates of 80% at
3 years [23], 98% at 5 [22] and 75% at 6 years [21]
follow-up. Possible explanations may include the lack of
financial compensation for participation, higher age and
lower population education levels. Also, there were some
demographic differences between groups, since migraine
sufferers were younger, more often females and had
higher depression rates and subjective memory com-
plaints, although their cognitive performance was un-
influenced by these factors [27]. Thirdly, the number of
participants with headache or migraine was small, and
the distinction between MH and NMH was not based
on a clinical assessment, but on a reliable instrument
(ID-Migraine), without further specifying the headache
subtypes in the NMH group. Finally, we did not calcu-
late the power or the sample size necessary to obtain dif-
ferences between groups. High-powered studies in the
future are needed to draw more definitive conclusions.
The strong aspects of this study are the detailed cogni-
tive assessment and the confirmation of migraine diag-
nosis at follow-up.
Conclusion
Although persisting migraine and non-migraine head-
ache may influence some measures of executive
performance these headaches are not associated with an
increased risk of cognitive decline, suggesting that re-
peated migraine attacks do not have a long-term impact
on cognition. However patients with migraine tend to
report more subjective cognitive complaints during
aging. Longer follow-up studies are necessary to corrob-
orate these results.
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